1 1374 159 IMPACT OF AN INTEGRATED YOGA THERAPY PROTOCOL ON INSULIN RESISTANCE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. OBJECTIVE: DIABETES MELLITUS (DM), CHARACTERIZED BY CHRONIC HYPERGLYCEMIA, IS ATTRIBUTED TO RELATIVE INSULIN DEFICIENCY OR RESISTANCE, OR BOTH. STUDIES HAVE SHOWN THAT YOGA CAN MODULATE PARAMETERS OF INSULIN RESISTANCE. THE PRESENT STUDY EXPLORED THE POSSIBLE BENEFICIAL EFFECTS OF INTEGRATED YOGA THERAPY WITH REFERENCE TO GLYCEMIC CONTROL AND INSULIN RESISTANCE (IR) IN INDIVIDUALS WITH DIABETES MAINTAINED ON STANDARD ORAL MEDICAL CARE WITH YOGA THERAPY, COMPARED TO THOSE ON STANDARD ORAL MEDICAL CARE ALONE. METHODS: IN THIS STUDY, THE SUBJECTS ON YOGA INTERVENTION COMPRISED 35 TYPE 2 DIABETICS, AND AN EQUAL NUMBER OF VOLUNTEERS CONSTITUTED THE CONTROL GROUP. SUBJECTS RANGED IN AGE FROM 30 TO 70 YEARS, WITH HEMOGLOBIN A1C (HBA1C) TEST MORE THAN 7%, AND WERE MAINTAINED ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS. BLOOD SAMPLES WERE DRAWN PRIOR TO AND AFTER 120 DAYS OF INTEGRATED YOGA THERAPY INTERVENTION. FASTING BLOOD GLUCOSE (FBG), POST-PRANDIAL BLOOD GLUCOSE (PPBG), HBA1C, INSULIN, AND LIPID PROFILE WERE ASSESSED IN BOTH THE INTERVENTION AND CONTROL GROUPS. RESULTS: THE INTERVENTION GROUP REVEALED SIGNIFICANT IMPROVEMENTS IN BODY MASS INDEX (BMI) (0.7 KG/M(2) MEDIAN DECREASE; P=0.001), FBG (20 MG/DL MEDIAN DECREASE; P<0.001), PPBG (33 MG/DL MEDIAN DECREASE; P<0.001), HBA1C (0.4% MEDIAN DECREASE; P<0.001), HOMEOSTATIC MODEL ASSESSMENT FOR INSULIN RESISTANCE (HOMA-IR) (1.2 MEDIAN DECREASE; P<0.001), CHOLESTEROL (13 MG/DL MEDIAN DECREASE, P=0.006), TRIACYLGLYCEROL (22 MG/DL MEDIAN DECREASE; P=0.027), LOW-DENSITY LIPOPROTEIN (6 MG/DL MEDIAN DECREASE; P=0.004), AND VERY-LOW-DENSITY LIPOPROTEIN LEVELS (4 MG/DL MEDIAN DECREASE; P=0.032). INCREASES IN HIGH-DENSITY LIPOPROTEIN AFTER 120 DAYS WERE NOT SIGNIFICANT (6 MG/DL MEDIAN INCREASE; P=0.15). HOWEVER, WHEN COMPARED TO CHANGES OBSERVED IN PATIENTS IN THE CONTROL GROUP, ALL THESE IMPROVEMENTS PROVED TO BE SIGNIFICANT. CONCLUSION: ADMINISTRATION OF INTEGRATED YOGA THERAPY TO INDIVIDUALS WITH DIABETES LEADS TO A SIGNIFICANT IMPROVEMENT IN GLYCEMIC CONTROL, INSULIN RESISTANCE, AND KEY BIOCHEMICAL PARAMETERS. 2022 2 2816 53 YOGA TRAINING IMPROVES METABOLIC PARAMETERS IN OBESE BOYS. YOGA HAS BEEN KNOWN TO HAVE STIMULATORY OR INHIBITORY EFFECTS ON THE METABOLIC PARAMETERS AND TO BE UNCOMPLICATED THERAPY FOR OBESITY. THE PURPOSE OF THE PRESENT STUDY WAS TO TEST THE EFFECT OF AN 8-WEEK OF YOGA-ASANA TRAINING ON BODY COMPOSITION, LIPID PROFILE, AND INSULIN RESISTANCE (IR) IN OBESE ADOLESCENT BOYS. TWENTY VOLUNTEERS WITH BODY MASS INDEX (BMI) GREATER THAN THE 95TH PERCENTILE WERE RANDOMLY ASSIGNED TO YOGA (AGE 14.7+/-0.5 YEARS, N=10) AND CONTROL GROUPS (AGE 14.6+/-1.0 YEARS, N=10). THE YOGA GROUP PERFORMED EXERCISES THREE TIMES PER WEEK AT 40~60% OF HEART-RATE RESERVE (HRR) FOR 8 WEEKS. IR WAS DETERMINED WITH THE HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE (HOMA-IR). AFTER YOGA TRAINING, BODY WEIGHT, BMI, FAT MASS (FM), AND BODY FAT % (BF %) WERE SIGNIFICANTLY DECREASED, AND FAT-FREE MASS AND BASAL METABOLIC RATE WERE SIGNIFICANTLY INCREASED THAN BASELINE VALUES. FM AND BF % WERE SIGNIFICANTLY IMPROVED IN THE YOGA GROUP COMPARED WITH THE CONTROL GROUP (P<0.05). TOTAL CHOLESTEROL (TC) WAS SIGNIFICANTLY DECREASED IN THE YOGA GROUP (P<0.01). HDL-CHOLESTEROL WAS DECREASED IN BOTH GROUPS (P<0.05). NO SIGNIFICANT CHANGES WERE OBSERVED BETWEEN OR WITHIN GROUPS FOR TRIGLYCERIDES, LDL-CHOLESTEROL, GLUCOSE, INSULIN, AND HOMA-IR. OUR FINDINGS SHOW THAT AN 8-WEEK OF YOGA TRAINING IMPROVES BODY COMPOSITION AND TC LEVELS IN OBESE ADOLESCENT BOYS, SUGGESTING THAT YOGA TRAINING MAY BE EFFECTIVE IN CONTROLLING SOME METABOLIC SYNDROME FACTORS IN OBESE ADOLESCENT BOYS. 2012 3 324 42 ANTHROPOMETRIC, BIOCHEMICAL AND CLINICAL PARAMETERS IN CLIMACTERIC YOGA PRACTITIONERS. OBJECTIVE: THIS STUDY AIMED TO EVALUATE ANTHROPOMETRIC, BIOCHEMICAL AND CLINICAL PARAMETERS IN CLIMACTERIC YOGA PRACTITIONERS. METHODS: THIS STUDY INVESTIGATED 108 CLIMACTERIC WOMEN. WE RECRUITED 28 WOMEN BETWEEN 40 AND 65 YEARS OLD WHO STARTED YOGA PRACTICES IN PREMENOPAUSE AND HAD ALREADY PRACTICED FOR AT LEAST 5 YEARS. AS CONTROLS, WE SELECTED 30 PHYSICAL ACTIVITY (PA) PRACTITIONERS WHO HAD PRACTICED FOR AT LEAST 5 YEARS AND 50 SEDENTARY WOMEN IN THE SAME AGE RANGE. WE CONDUCED ANTHROPOMETRIC, BIOCHEMICAL AND BLOOD PRESSURE MEASUREMENTS. RESULTS: THE YOGA GROUP HAD SIGNIFICANTLY LOWER FASTING BLOOD GLUCOSE THAN THE PA PRACTITIONERS AND SEDENTARY WOMEN. YOGA PRACTITIONERS ALSO HAD LOWER WEIGHT, BODY MASS INDEX, WAIST CIRCUMFERENCE, BODY FAT PERCENTAGE AND WAIST-TO-HEIGHT RATIO; HIGHER LEVELS OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL; LOWER LEVELS OF TRIGLYCERIDES, INSULIN, HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE, URIC ACID, APOLIPOPROTEIN B AND HIGH-SENSITIVITY C-REACTIVE PROTEIN; AND LOWER FREQUENCY OF METABOLIC SYNDROME, LIPID ACCUMULATION PRODUCT, VISCERAL ADIPOSITY INDEX AND SYSTOLIC BLOOD PRESSURE THAN THE SEDENTARY WOMEN. CONCLUSION: YOGA PRACTITIONERS HAD LOWER GLUCOSE SERUM CONCENTRATIONS THAN THE PA PRACTITIONERS AND SEDENTARY WOMEN. OVERALL, THE YOGA GROUP ALSO HAD BETTER ANTHROPOMETRIC, BIOCHEMICAL AND CLINICAL VARIABLES THAN THE OTHER GROUPS. ALTHOUGH FURTHER INVESTIGATION IS REQUIRED, YOGA PRACTICE IN PREMENOPAUSE SEEMS TO BE BENEFICIAL FOR WOMEN WHEN THEY REACH MENOPAUSE. 2022 4 1030 47 EFFECTS OF YOGA EXERCISE ON SERUM ADIPONECTIN AND METABOLIC SYNDROME FACTORS IN OBESE POSTMENOPAUSAL WOMEN. OBJECTIVE: REGULAR AND CONTINUOUS YOGA EXERCISE IS ONE OF THE MOST IMPORTANT NONPHARMACOLOGICAL METHODS OF IMPROVING SERUM LIPID CONCENTRATIONS, ADIPOSE TISSUE, AND METABOLIC SYNDROME FACTORS. THE PURPOSE OF THIS STUDY WAS TO ANALYZE THE EFFECTS OF YOGA EXERCISE ON SERUM ADIPONECTIN AND METABOLIC SYNDROME FACTORS IN OBESE POSTMENOPAUSAL KOREAN WOMEN. METHODS: SIXTEEN HEALTHY POSTMENOPAUSAL WOMEN AGED 54.50 +/- 2.75 YEARS WITH MORE THAN 36% BODY FAT WERE RANDOMLY ASSIGNED TO EITHER A YOGA EXERCISE GROUP (N = 8) OR TO A "NO EXERCISE" CONTROL GROUP (N = 8). THE VARIABLES OF BODY COMPOSITION, VISCERAL FAT, SERUM ADIPONECTIN, AND METABOLIC SYNDROME FACTORS WERE MEASURED IN ALL THE PARTICIPANTS BEFORE AND AFTER THE 16-WEEK STUDY. RESULTS: BODY WEIGHT, PERCENTAGE OF BODY FAT, LEAN BODY MASS, BODY MASS INDEX, WAIST CIRCUMFERENCE, AND VISCERAL FAT AREA HAD SIGNIFICANTLY DECREASED. HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AND ADIPONECTIN HAD SIGNIFICANTLY INCREASED, BUT TOTAL CHOLESTEROL, TRIGLYCERIDE, LOW-DENSITY LIPOPROTEIN CHOLESTEROL, BLOOD PRESSURE, INSULIN, GLUCOSE, AND HOMOEOSTASIS MODEL ASSESSMENT-INSULIN RESISTANCE HAD SIGNIFICANTLY DECREASED. SERUM ADIPONECTIN CONCENTRATIONS WERE SIGNIFICANTLY CORRELATED WITH WAIST CIRCUMFERENCE, HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, DIASTOLIC BLOOD PRESSURE, AND HOMOEOSTASIS MODEL ASSESSMENT-INSULIN RESISTANCE IN THE POSTYOGA EXERCISE GROUP. CONCLUSIONS: OUR FINDINGS INDICATE THAT YOGA EXERCISE IMPROVES ADIPONECTIN LEVEL, SERUM LIPIDS, AND METABOLIC SYNDROME RISK FACTORS IN OBESE POSTMENOPAUSAL WOMEN. CONSEQUENTLY, YOGA EXERCISE WILL BE EFFECTIVE IN PREVENTING CARDIOVASCULAR DISEASE CAUSED BY OBESITY IN OBESE POSTMENOPAUSAL KOREAN WOMEN. 2012 5 1319 25 HEART RATE VARIABILITY, FLOW, MOOD AND MENTAL STRESS DURING YOGA PRACTICES IN YOGA PRACTITIONERS, NON-YOGA PRACTITIONERS AND PEOPLE WITH METABOLIC SYNDROME. HEART RATE VARIABILITY (HRV) AND RESPIRATORY SINUS ARRHYTHMIA ARE DIRECTLY ASSOCIATED WITH AUTONOMIC FLEXIBILITY, SELF-REGULATION AND WELL-BEING, AND INVERSELY ASSOCIATED WITH PHYSIOLOGICAL STRESS, PSYCHOLOGICAL STRESS AND PATHOLOGY. YOGA ENHANCES AUTONOMIC ACTIVITY, MITIGATES STRESS AND BENEFITS STRESS-RELATED CLINICAL CONDITIONS, YET THE RELATIONSHIP BETWEEN AUTONOMIC ACTIVITY AND PSYCHOPHYSIOLOGICAL RESPONSES DURING YOGA PRACTICES AND STRESSFUL STIMULI HAS NOT BEEN WIDELY EXPLORED. THIS EXPERIMENTAL STUDY EXPLORED THE RELATIONSHIP BETWEEN HRV, MOOD STATES AND FLOW EXPERIENCES IN REGULAR YOGA PRACTITIONERS (YP), NON-YOGA PRACTITIONERS (NY) AND PEOPLE WITH METABOLIC SYNDROME (METS), DURING MENTAL ARITHMETIC STRESS TEST (MAST) AND VARIOUS YOGA PRACTICES. THE STUDY FOUND THAT THE MAST PLACED A CARDIO-AUTONOMIC BURDEN IN ALL PARTICIPANTS WITH THE YP GROUP SHOWING THE GREATEST REACTIVITY AND THE MOST RAPID RECOVERY, WHILE THE METS GROUP HAD SIGNIFICANTLY BLUNTED RECOVERY. THE YP GROUP ALSO REPORTED A HEIGHTENED EXPERIENCE OF FLOW AND POSITIVE MOOD STATES COMPARED TO NY AND METS GROUPS AS WELL AS HAVING A HIGHER VAGAL TONE DURING ALL RESTING CONDITIONS. THESE RESULTS SUGGEST YOGA PRACTITIONERS HAVE A GREATER HOMEOSTATIC CAPACITY AND AUTONOMIC, METABOLIC AND PHYSIOLOGICAL RESILIENCE. FURTHER STUDIES ARE NOW NEEDED TO DETERMINE IF REGULAR YOGA PRACTICE MAY IMPROVE AUTONOMIC FLEXIBILITY IN NON-YOGA PRACTITIONERS AND METABOLIC SYNDROME PATIENTS. CLINICAL TRIAL NO 'ACTRN 2614001075673'. 2016 6 679 46 EFFECT OF A YOGA PROGRAM ON GLUCOSE METABOLISM AND BLOOD LIPID LEVELS IN ADOLESCENT GIRLS WITH POLYCYSTIC OVARY SYNDROME. OBJECTIVE: TO ASSESS THE EFFICACY OF YOGA THERAPY ON GLUCOSE METABOLISM AND BLOOD LIPID VALUES IN ADOLESCENT GIRLS WITH POLYCYSTIC OVARY SYNDROME (PCOS). METHODS: A PROSPECTIVE, RANDOMIZED, INTERVENTIONAL CONTROLLED TRIAL RECRUITED 90 ADOLESCENTS AGED BETWEEN 15 AND 18 YEARS WHO MET THE ROTTERDAM CRITERIA FOR PCOS. A YOGA GROUP PRACTICED SURYANAMASKARA, ASANAS, PRANAYAMA, AND MEDITATION 1 HOUR PER DAY EACH DAY FOR 12 WEEKS WHILE ANOTHER GROUP PRACTICED CONVENTIONAL PHYSICAL EXERCISES. THE MANN-WHITNEY U TEST WAS USED TO COMPARE SCORE CHANGES BETWEEN THE 2 GROUPS. RESULTS: THE CHANGES IN FASTING INSULIN, FASTING BLOOD GLUCOSE, AND HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE WERE SIGNIFICANTLY DIFFERENT IN THE 2 GROUPS (P<0.05). EXCEPT FOR HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, THE CHANGES IN BLOOD LIPID VALUES WERE ALSO SIGNIFICANTLY DIFFERENT (P<0.05). THE CHANGES IN BODY MASS INDEX, WAIST CIRCUMFERENCE, HIP CIRCUMFERENCE, AND WAIST-TO-HIP RATIO, HOWEVER, WERE NOT SIGNIFICANTLY DIFFERENT (P>0.05). CONCLUSION: YOGA WAS FOUND TO BE MORE EFFECTIVE THAN CONVENTIONAL PHYSICAL EXERCISES IN IMPROVING GLUCOSE, LIPID, AND INSULIN VALUES, INCLUDING INSULIN RESISTANCE VALUES, IN ADOLESCENT GIRLS WITH PCOS INDEPENDENT OF ANTHROPOMETRIC CHANGES. CENTRAL TRIAL REGISTRY OF INDIA NO.: REFCTRI-2008 000291. 2012 7 1089 32 EFFECTS OF YOGA ON THE AUTONOMIC NERVOUS SYSTEM, GAMMA-AMINOBUTYRIC-ACID, AND ALLOSTASIS IN EPILEPSY, DEPRESSION, AND POST-TRAUMATIC STRESS DISORDER. A THEORY IS PROPOSED TO EXPLAIN THE BENEFITS OF YOGA PRACTICES IN DIVERSE, FREQUENTLY COMORBID MEDICAL CONDITIONS BASED ON THE CONCEPT THAT YOGA PRACTICES REDUCE ALLOSTATIC LOAD IN STRESS RESPONSE SYSTEMS SUCH THAT OPTIMAL HOMEOSTASIS IS RESTORED. IT IS HYPOTHESIZED THAT STRESS INDUCES (1) IMBALANCE OF THE AUTONOMIC NERVOUS SYSTEM (ANS) WITH DECREASED PARASYMPATHETIC NERVOUS SYSTEM (PNS) AND INCREASED SYMPATHETIC NERVOUS SYSTEM (SNS) ACTIVITY, (2) UNDERACTIVITY OF THE GAMMA AMINO-BUTYRIC ACID (GABA) SYSTEM, THE PRIMARY INHIBITORY NEUROTRANSMITTER SYSTEM, AND (3) INCREASED ALLOSTATIC LOAD. IT IS FURTHER HYPOTHESIZED THAT YOGA-BASED PRACTICES (4) CORRECT UNDERACTIVITY OF THE PNS AND GABA SYSTEMS IN PART THROUGH STIMULATION OF THE VAGUS NERVES, THE MAIN PERIPHERAL PATHWAY OF THE PNS, AND (5) REDUCE ALLOSTATIC LOAD. DEPRESSION, EPILEPSY, POST TRAUMATIC STRESS DISORDER (PTSD), AND CHRONIC PAIN EXEMPLIFY MEDICAL CONDITIONS THAT ARE EXACERBATED BY STRESS, HAVE LOW HEART RATE VARIABILITY (HRV) AND LOW GABAERGIC ACTIVITY, RESPOND TO PHARMACOLOGIC AGENTS THAT INCREASE ACTIVITY OF THE GABA SYSTEM, AND SHOW SYMPTOM IMPROVEMENT IN RESPONSE TO YOGA-BASED INTERVENTIONS. THE OBSERVATION THAT TREATMENT RESISTANT CASES OF EPILEPSY AND DEPRESSION RESPOND TO VAGAL NERVE STIMULATION CORROBORATES THE NEED TO CORRECT PNS UNDERACTIVITY AS PART OF A SUCCESSFUL TREATMENT PLAN IN SOME CASES. ACCORDING TO THE PROPOSED THEORY, THE DECREASED PNS AND GABAERGIC ACTIVITY THAT UNDERLIES STRESS-RELATED DISORDERS CAN BE CORRECTED BY YOGA PRACTICES RESULTING IN AMELIORATION OF DISEASE SYMPTOMS. THIS HAS FAR-REACHING IMPLICATIONS FOR THE INTEGRATION OF YOGA-BASED PRACTICES IN THE TREATMENT OF A BROAD ARRAY OF DISORDERS EXACERBATED BY STRESS. 2012 8 812 40 EFFECT OF YOGA ON CARDIAC AUTONOMIC DYSFUNCTION AND INSULIN RESISTANCE IN NON-DIABETIC OFFSPRING OF TYPE-2-DIABETES PARENTS: A RANDOMIZED CONTROLLED STUDY. OBJECTIVE: THE PRESENT STUDY WAS AIMED TO DETERMINE THE EFFECT OF YOGA PROGRAM ON CARDIAC AUTONOMIC DYSFUNCTION AND INSULIN RESISTANCE IN NON-DIABETIC OFFSPRING OF DIABETES PARENTS. METHODS: A RANDOMIZED PASSIVE-CONTROLLED STUDY WAS CONDUCTED ON 64 NON-DIABETIC OFFSPRING OF TYPE-2-DIABETES PARENTS (MEAN-AGE:25.17YEARS). YOGA GROUP PARTICIPANTS RECEIVED YOGA TRAINING FOR 8 WEEKS. HEART-RATE VARIABILITY (HRV) INDICES: LOW FREQUENCY (LF), HIGH FREQUENCY (HF) AND LF/HF RATIO; FASTING BLOOD GLUCOSE (FBG), ORAL GLUCOSE TOLERANCE TEST (OGTT) AND INSULIN RESISTANCE (IR) WERE ESTIMATED AT BASELINE AND AFTER 8-WEEKS OF INTERVENTION. RESULTS: WE FOUND A SIGNIFICANT DECREASE IN LF (P=0.005), LF/HF RATIO (P=0.004), IR (P<0.001), OGTT (P=0.003) AND INCREASE IN HF (P=0.022) IN YOGA GROUP PARTICIPANTS. CONTROL GROUP PARTICIPANTS DID NOT SHOW ANY SIGNIFICANT CHANGE IN ANY VARIABLES. CONCLUSIONS: IMPROVEMENT IN CARDIAC AUTONOMIC FUNCTION AND INSULIN RESISTANCE BY YOGA TRAINING IMPLIES THAT YOGA CAN REDUCE THE RISK OF DEVELOPMENT OF DIABETES IN OFFSPRING OF DIABETES PARENTS. 2019 9 939 55 EFFECTS OF 12 WEEKS PRACTICE OF YOGA ON HEART RATE VARIABILITY IN MALES WITH TYPE 2 DIABETES RECEIVING ORAL ANTIDIABETIC DRUGS: A RANDOMIZED CONTROL TRIAL. OBJECTIVE: TO INVESTIGATE THE EFFECTS OF 12 WEEKS PRACTICE OF A STRUCTURED YOGA MODULE ON HEART RATE VARIABILITY (HRV) AND CARDIOMETABOLIC RISKS IN PATIENTS WITH TYPE 2 DIABETES (T2D) RECEIVING SIMILAR KIND OF ORAL ANTIDIABETIC DRUGS (OAD) WITH YOGA THERAPY AND WITHOUT YOGA THERAPY, MATCHED FOR ALL THE KNOWN CONFOUNDERS. DESIGN: PARALLEL DESIGN INTERVENTIONAL (RANDOMIZED CONTROL TRIAL) STUDY. SUBJECTS: EIGHTY TREATMENT-NAIVE MALES WITH T2D WERE RANDOMIZED INTO CONTROL GROUP (N = 40) AND STUDY GROUP (N = 40). INTERVENTION: STUDY GROUP PARTICIPANTS RECEIVED A STRUCTURED YOGA THERAPY THAT INCLUDED ASANA AND PRANAYAMA PRACTICE FOR 12 WEEKS IN ADDITION TO OAD, WHEREAS CONTROL GROUP PARTICIPANTS RECEIVED OAD ALONE. OUTCOME MEASURES: BEFORE AND AFTER INTERVENTION, BP PARAMETERS, RATE PRESSURE PRODUCT (RPP) AS THE MARKER OF MYOCARDIAL STRESS, TOTAL POWER (TP) OF HRV, LOW-FREQUENCY TO HIGH-FREQUENCY (LF-HF) RATIO OF HRV, HOMEOSTATIC MODEL OF INSULIN RESISTANCE (HOMA-IR), LIPID PROFILE AND LIPID RISK FACTORS, MALONDIALDEHYDE (MDA), AND HIGH-SENSITIVE C-REACTIVE PROTEIN (HSCRP) WERE MEASURED. TP OF HRV WAS DEFINED AS THE PRIMARY OUTCOME. ASSOCIATION OF TP (THE MARKER OF HRV) AND LF-HF RATIO (THE MARKER OF SYMPATHOVAGAL BALANCE) WITH CARDIOMETABOLIC PARAMETERS WAS ASSESSED BY CORRELATION AND REGRESSION ANALYSES. RESULTS: AFTER 12 WEEKS YOGA THERAPY, THERE WAS SIGNIFICANT REDUCTION IN CARDIOMETABOLIC RISKS (TP OF HRV, RPP, LIPID RISKS FACTORS, LEVELS OF MDA, AND HSCRP) IN STUDY GROUP SUBJECTS COMPARED WITH CONTROL SUBJECTS THAT DID NOT RECEIVE YOGA THERAPY. ALL CARDIOMETABOLIC RISK FACTORS WERE SIGNIFICANTLY CORRELATED WITH TP IN STUDY GROUP, HAVING MAXIMUM SIGNIFICANCE WITH HOMEOSTATIC MODEL OF INSULIN SECRETION (R = 0.502, P